The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 21, 2023

Filed:

Jun. 25, 2019
Applicant:

H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FL (US);

Inventors:

Alan F. List, Tampa, FL (US);

Sheng Wei, Tampa, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 47/00 (2006.01); A61K 47/50 (2017.01); C07K 14/705 (2006.01); C07K 14/735 (2006.01); C07K 19/00 (2006.01); A61K 47/69 (2017.01); G01N 33/68 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70503 (2013.01); A61K 38/177 (2013.01); A61K 38/1774 (2013.01); A61K 47/6913 (2017.08); C07K 14/705 (2013.01); C07K 14/70596 (2013.01); C07K 19/00 (2013.01); G01N 33/6872 (2013.01); A61K 38/00 (2013.01); A61K 47/6911 (2017.08); C07K 14/70535 (2013.01); C07K 2319/00 (2013.01); C07K 2319/30 (2013.01); C07K 2319/32 (2013.01); C07K 2319/70 (2013.01); G01N 2333/4727 (2013.01); G01N 2333/70503 (2013.01); G01N 2500/02 (2013.01);
Abstract

Disclosed are compositions and methods for treating disease or condition caused or exacerbated by S100A9 activity, such as myelodysplastic syndromes (MDS) using a composition comprising an effective amount of a CD33/S100A9 inhibitor.


Find Patent Forward Citations

Loading…